A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum Publisher Pubmed

Balighi K^{1, 2} ; Mousavi A¹ ; Hatami P¹ ; Daneshpazhooh M^{1, 2} ; Ghiasi M^{1, 2} ; Hesari KK^{1, 3} ; Aryanian Z^{1, 4} ; Kavyani M¹

Source: Dermatologic Therapy Published:2022

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran, Dermatologic Therapy (2022)

2. Sars-Cov-2 Vaccination and Practical Points in Psoriasis Patients: A Narrative Review, Dermatologic Therapy (2022)

3. Dexamethasone or Prednisone: Which One Should Be the Corticosteroid of Choice in Patients With Pemphigus Vulgaris?, Dermatologic Therapy (2022)

Experts (# of related papers)

View all Related Experts

Zeinab Aryanian (12)

Kamran Balighi (12)

Other Related Docs

4. Kaposi's Sarcoma in a Patient With Pemphigus Vulgaris Mimicking Exacerbation of Pemphigus, Cancer Reports (2023)

5. Covid Outcome in Pemphigus: Does Rituximab Make Pemphigus Patients Susceptible to More Severe Covid-19?, Journal of Cosmetic Dermatology (2023)

6. A Comparative Study of Demographic and Clinical Criteria Between Male and Female Patients With Pemphigus Referred to a Referral Hospital in Iran, Dermatology Research and Practice (2024)

7. Prevalence and Management of Chronic Hepatitis B in Pemphigus and Pemphigoid Patients: New Evidence for the Safety of Rituximab, Dermatologic Therapy (2022)

8. Multiple Cycles of Rituximab Therapy for Pemphigus: A Group of Patients With Difficult- To-Treat Disease or a Consequence of Late Rituximab Initiation?, Dermatologic Therapy (2022)

9. Serious Health Threat of Mucormycosis During the Ongoing Covid-19 Pandemic: What Dermatologists Need to Know in This Regard, International Journal of Dermatology (2022)

10. Rituximab As a Maintenance Treatment in Patients With Pemphigus Vulgaris: When Is the Right Time for Discontinuation?, Journal of Cosmetic Dermatology (2024)

11. Two Asymptomatic Facial Erythematous Macules in an Adult Male, Skin Health and Disease (2023)

12. Comparative Analysis of Demographics and Clinical Outcomes in Patients With Pemphigus Vulgaris and Foliaceus With High Versus Normal Anti-Desmoglein Levels Post-Complete Remission, Archives of Dermatological Research (2025)

Style	Citing Format
MLA	Balighi K, et al.. "A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum." Dermatologic Therapy, vol. 35, no. 7, 2022, pp. -.
APA	Balighi K, Mousavi A, Hatami P, Daneshpazhooh M, Ghiasi M, Hesari KK, Aryanian Z, Kavyani M (2022). A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum. Dermatologic Therapy, 35(7), -.
Chicago	Balighi K, Mousavi A, Hatami P, Daneshpazhooh M, Ghiasi M, Hesari KK, Aryanian Z, Kavyani M. "A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum." Dermatologic Therapy 35, no. 7 (2022): -.
Harvard	Balighi K et al. (2022) 'A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum', Dermatologic Therapy, 35(7), pp. -.
Vancouver	Balighi K, Mousavi A, Hatami P, Daneshpazhooh M, Ghiasi M, Hesari KK, et al.. A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum. Dermatologic Therapy. 2022;35(7):-.
BibTex	@article{ author = {Balighi K and Mousavi A and Hatami P and Daneshpazhooh M and Ghiasi M and Hesari KK and Aryanian Z and Kavyani M}, title = {A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum}, journal = {Dermatologic Therapy}, volume = {35}, number = {7}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Balighi K AU - Mousavi A AU - Hatami P AU - Daneshpazhooh M AU - Ghiasi M AU - Hesari KK AU - Aryanian Z AU - Kavyani M TI - A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum JO - Dermatologic Therapy VL - 35 IS - 7 SP - EP - PY - 2022 ER -